Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Investors Business Daily
Investors Business Daily
Business
INVESTOR'S BUSINESS DAILY and JULIE MAK

IDEXX Laboratories Stock Earns IBD Stock Rating Upgrade

One important metric to look for in a stock is an 80 or higher Relative Strength Rating. IDEXX Laboratories stock now clears that threshold, with a jump from 79 to 83 Wednesday.

When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.

This proprietary rating identifies market leadership by showing how a stock's price action over the last 52 weeks measures up against that of the other stocks in our database.

History shows that the best stocks tend to have an RS Rating of at least 80 in the early stages of their moves.

Looking For Winning Stocks? Try This Simple Routine

Is IDEXX Laboratories Stock A Buy?

On Monday, IDEXX Laboratories stock broke out of a cup with handle pattern with a 484.074 entry. The stock is a bit extended beyond its buying zone. See if the stock pulls back and form another buying opportunity. Read "Looking For The Next Big Stock Market Winners? Start With These 3 Steps" for more tips.

 

The company showed 16% EPS growth in its most recent report, while sales growth came in at 9%.

IDEXX Laboratories stock holds the No. 2 rank among its peers in the Medical-Systems/Equipment industry group. IDEXX Laboratories and Intuitive Surgical are also among the group's highest-rated stocks.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.